Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

  • This share is currently suspended. It was suspended at a price of 33.50
  • There is currently no data for SIS

Director/PDMR Shareholding

18 Sep 2024 07:00

RNS Number : 6632E
Science in Sport PLC
18 September 2024
 

Science in Sport plc

("Science in Sport" or the "Company")

Director/PDMR Shareholding

Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts and the gym lifestyle community, announces that it has been notified of the following transaction by Christopher Welsh, Chief Financial Officer. Following this transaction Christopher Welsh holds 208,284 ordinary shares in the Company, representing 0.09% of the issued share capital.

The information below set out in accordance with the requirement of the EU Market Abuse Regulation provides further detail.

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Christopher Welsh

2

Reason for notification

 

a.

Position/Status

Chief Financial Officer

b.

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Science in Sport plc

b.

LEI

213800FWYWBJFJPPJ981

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary Shares of 10 pence each

 ISIN: GB00BBPV5329

b.

Nature of the transaction

Purchase of shares

 

c.

Price(s) and volume(s)

Price(s)

Volume(s)

24.5 pence

61,225

d.

Aggregated information

- Aggregated Volume

- Price

 n/a single transaction

e.

Date of the transaction

17 September 2024

f.

Place of the transaction

London Stock Exchange, AIM

 

 

 

For further information:

Science in Sport plc

T: +44 (0) 20 7400 3700

Daniel Wright, Executive Chairman

Daniel Lampard, Chief Operating Officer

Christopher Welsh, Chief Financial Officer

 

Panmure Liberum Limited (Nominated Adviser and Broker)

T: +44 (0) 20 3100 2000

Richard Lindley

John More

Anake Singh

 

 

About Science in Sport plc

Headquartered in London, Science in Sport plc is a leading sports nutrition business that develops, manufactures, and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the active lifestyle community. The Company has two highly regarded brands, PhD Nutrition, a premium active-nutrition brand targeting the active lifestyle community, and SiS, a leading endurance nutrition brand among elite athletes and professional sports teams.

The two brands sell through the Company's phd.com and scienceinsport.com digital platforms, third-party online sites, including Amazon and eBay, and extensive retail distribution in the UK and internationally, including major supermarkets, high street chains and specialist sports retailers. This omnichannel footprint enables the Company to address the full breadth of the sports nutrition market.

PhD is one of the UK's leading active nutrition brands with a reputation for high quality and product innovation. The brand has grown rapidly since its launch in 2005. The range now comprises powders, bars, and supplements, including the high protein, low sugar range, PhD Smart.

SiS, a leading endurance nutrition business founded in 1992, has a core range comprising gels, powders and bars focused on energy, hydration, and recovery. SiS is an official endurance nutrition supplier to over 320 professional teams, organisations, and national teams worldwide. SiS supplies more than 150 professional football clubs in the UK, Europe, and the USA. 

SiS is Performance Solutions partner to Ineos Grenadiers cycling team, and Tottenham Hotspur and CGC Nice football clubs. 

For further information, please visit phd.com and scienceinsport.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGUGDCLSBDGSI
Date   Source Headline
11th Sep 20197:00 amRNSAppointment of Chief Financial Officer
8th Aug 20197:00 amRNSLaunch of SiS Plant Protein Range
31st Jul 20194:39 pmRNSNotification of Major Holdings
26th Jul 201912:27 pmRNSNotification of Major Holdings
25th Jul 20193:17 pmRNSNotification of Major Holdings
9th Jul 20197:00 amRNSHalf Year Trading Update
4th Jul 20195:00 pmRNSNOTIFICATION OF MAJOR HOLDINGS
28th Jun 20193:11 pmRNSNotification of Major Holdings
28th Jun 201911:35 amRNSNotification of Major Holdings
27th Jun 20194:15 pmRNSNotification of Major Holdings
27th Jun 201911:54 amRNSNotification of Major Holdings
27th Jun 20197:00 amRNSAGM Statement
25th Jun 20195:20 pmRNSNotification of Major Holdings
25th Jun 20195:15 pmRNSNotification of Major Holdings
12th Jun 20197:00 amRNSDirectorate Change
4th Jun 20197:00 amRNSOpens new e-commerce facility
24th May 20197:00 amRNSPosting of Annual Report & Notice of AGM
8th May 20197:00 amRNSPhD launches vegan Smart Bar Plant
2nd May 20197:00 amRNSSiS: Exclusive Nutrition Provider to Team INEOS
30th Apr 20197:00 amRNSLaunch of New PhD Website
3rd Apr 20194:28 pmRNSGrant of Options
27th Mar 201912:23 pmRNSHolding(s) in Company
21st Mar 20197:00 amRNSIssue of Equity
20th Mar 20197:00 amRNSFinal Results
4th Mar 20197:00 amRNSSiS: New Product Range for Footballers
27th Feb 20197:00 amRNSIssue of Equity
21st Feb 20197:00 amRNSSenior Management Appointments
29th Jan 20195:42 pmRNSHolding(s) in Company
21st Jan 20197:00 amRNSCapital Markets Day
14th Jan 20197:00 amRNSHolding(s) in Company
9th Jan 20197:00 amRNSPre-Close Trading Update
8th Jan 20191:10 pmRNSHolding(s) in Company
7th Jan 20192:00 pmRNSIssue of Equity
7th Dec 20185:15 pmRNSHolding(s) in Company
6th Dec 201812:15 pmRNSHolding(s) in Company
6th Dec 20188:01 amRNSCompletion of Acquisition
5th Dec 20185:09 pmRNSHolding(s) in Company - replacement
5th Dec 20185:00 pmRNSHolding(s) in Company
5th Dec 20184:58 pmRNSHolding(s) in Company
5th Dec 20184:48 pmRNSDirector/PDMR Shareholding
3rd Dec 201811:35 amRNSResult of General Meeting
16th Nov 20182:30 pmRNSHolding(s) in Company
14th Nov 20183:40 pmRNSResults of Placing
14th Nov 201811:05 amRNSSecond Price Monitoring Extn
14th Nov 201811:00 amRNSPrice Monitoring Extension
14th Nov 20187:00 amRNSProposed Acquisition & Placing
17th Oct 20187:00 amRNSLaunch into Chinese market
19th Sep 20187:00 amRNSHalf-year Report
13th Sep 201810:15 amRNSDirectorate Update
22nd Aug 20187:00 amRNSChange of Registered Office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.